ZA921247B - Steroid formulations - Google Patents

Steroid formulations

Info

Publication number
ZA921247B
ZA921247B ZA921247A ZA921247A ZA921247B ZA 921247 B ZA921247 B ZA 921247B ZA 921247 A ZA921247 A ZA 921247A ZA 921247 A ZA921247 A ZA 921247A ZA 921247 B ZA921247 B ZA 921247B
Authority
ZA
South Africa
Prior art keywords
steroid formulations
steroid
formulations
Prior art date
Application number
ZA921247A
Other languages
English (en)
Inventor
Joy Elaine Saunders
Elaine Saunders Joy
Original Assignee
Fisons Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ag filed Critical Fisons Ag
Publication of ZA921247B publication Critical patent/ZA921247B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
ZA921247A 1991-02-23 1992-02-20 Steroid formulations ZA921247B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103824A GB9103824D0 (en) 1991-02-23 1991-02-23 Formulation

Publications (1)

Publication Number Publication Date
ZA921247B true ZA921247B (en) 1992-10-28

Family

ID=10690478

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921247A ZA921247B (en) 1991-02-23 1992-02-20 Steroid formulations

Country Status (13)

Country Link
CN (1) CN1065010A (xx)
AU (1) AU1247192A (xx)
BE (1) BE1004177A4 (xx)
FR (1) FR2673104A1 (xx)
GB (1) GB9103824D0 (xx)
GR (1) GR1001511B (xx)
IE (1) IE920516A1 (xx)
IL (1) IL101010A0 (xx)
IT (1) IT1254627B (xx)
MX (1) MX9200748A (xx)
PT (1) PT100150A (xx)
WO (1) WO1992014473A1 (xx)
ZA (1) ZA921247B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
DE10064950A1 (de) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
EP2057982A1 (en) * 2007-11-09 2009-05-13 Archimedes Development Limited Intranasal compositions
WO2013049539A1 (en) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. A method of blocking or trapping allergens
EP3694524A1 (en) * 2017-10-11 2020-08-19 Lifescience AS N-acetylneuraminic acid compositions and methods of use
MX2021009595A (es) * 2019-02-11 2021-09-08 Reckitt Benckiser Health Ltd Composicion novedosa.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol

Also Published As

Publication number Publication date
PT100150A (pt) 1993-05-31
IE920516A1 (en) 1992-08-26
AU1247192A (en) 1992-09-15
GB9103824D0 (en) 1991-04-10
IT1254627B (it) 1995-09-28
WO1992014473A1 (en) 1992-09-03
IL101010A0 (en) 1992-11-15
FR2673104A1 (fr) 1992-08-28
GR1001511B (el) 1994-02-28
ITMI920393A1 (it) 1993-08-21
CN1065010A (zh) 1992-10-07
MX9200748A (es) 1992-10-01
BE1004177A4 (fr) 1992-10-06
ITMI920393A0 (it) 1992-02-21

Similar Documents

Publication Publication Date Title
GB9118028D0 (en) Improved transdrmal formulations
GB9207832D0 (en) Formulations
GB9102579D0 (en) Compositions
IL100532A0 (en) Novel steroids
ZA921247B (en) Steroid formulations
GB9214390D0 (en) Formulations
GB9114099D0 (en) Compositions
GB9101592D0 (en) Compositions
GB9101655D0 (en) Compositions
GB9101654D0 (en) Compositions
GB9124661D0 (en) Formulations
GB9100997D0 (en) Formulations
GB9107640D0 (en) Formulations
GB9105373D0 (en) Formulations
GB9105082D0 (en) Formulations
GB9105386D0 (en) Formulations
GB9124723D0 (en) Formulations
GB9120396D0 (en) Formulations
GB9107669D0 (en) Formulations
GB9107641D0 (en) Formulations
GB9202474D0 (en) Formulations
GB9213271D0 (en) Formulations
GB9205738D0 (en) Formulations
GB9205739D0 (en) Formulations
GB9224539D0 (en) Formulations